Stock listing
MFY Stock Price, News, Filings & Events — Mochida Pharmaceutical Co., Ltd.
Selected listing: MFY · DUS · EUR · DE
This page tracks Mochida Pharmaceutical Co., Ltd.'s MFY:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MFY:DUS. MFY:DUS is the stock-level entry point for investors researching Mochida Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- MFY:DUS
- Asset type
- Stock
- Market cap
- $702.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- DUS
- Currency
- EUR
Mochida Pharmaceutical Co., Ltd. MFY:DUS stock context
This page tracks Mochida Pharmaceutical Co., Ltd.'s MFY:DUS listing on DUS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MFY:DUS. MFY:DUS is the stock-level entry point for investors researching Mochida Pharmaceutical Co., Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Mochida Pharmaceutical Co., Ltd.
Notice Regarding the Status of the Acquisition of Own Shares
September 1, 2026
[Summary] Consolidated Financial Results for the Three Months Ended June 30, 2026
August 3, 2026
Notice Regarding the Status of Acquisition of Own Shares
July 1, 2026
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
Research Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. investor report
Review AI stock analysis and investor report context for MFY:DUS.
Mochida Pharmaceutical Co., Ltd. company profile
View the public company page for Mochida Pharmaceutical Co., Ltd. on 6ix.
Mochida Pharmaceutical Co., Ltd. news
Read company news and market updates connected to Mochida Pharmaceutical Co., Ltd..
Mochida Pharmaceutical Co., Ltd. investor events
Find investor webinars, events, and replay context for Mochida Pharmaceutical Co., Ltd..
Alternate listings
4534:TSE
JP · JPY
Alternate listing for Mochida Pharmaceutical Co., Ltd.; the primary context on this page is MFY:DUS.
859288:LSX
DE · EUR
Alternate listing for Mochida Pharmaceutical Co., Ltd.; the primary context on this page is MFY:DUS.
MFY:FWB
DE · EUR
Alternate listing for Mochida Pharmaceutical Co., Ltd.; the primary context on this page is MFY:DUS.
MCPMF:OTC
US · USD
Alternate listing for Mochida Pharmaceutical Co., Ltd.; the primary context on this page is MFY:DUS.
859288:LS
DE · EUR
Alternate listing for Mochida Pharmaceutical Co., Ltd.; the primary context on this page is MFY:DUS.